Company profile for Tempus

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Tempus is making precision medicine a reality through the power and promise of data and artificial intelligence. With the world’s largest library of clinical and molecular data, and an operating system to make that data accessible and useful, we enable physicians to make real-time, data-driven decisions to deliver personalized patient care, and in parallel, facilitate discovery, development, and delivery of optimized therap...
Tempus is making precision medicine a reality through the power and promise of data and artificial intelligence. With the world’s largest library of clinical and molecular data, and an operating system to make that data accessible and useful, we enable physicians to make real-time, data-driven decisions to deliver personalized patient care, and in parallel, facilitate discovery, development, and delivery of optimized therapeutic options for patients through distinctive solution sets. With the right data, we can accelerate cancer research. We can usher in an era of true precision medicine and revolutionize.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
600 W Chicago Ave. Ste 510, Chicago, IL 60654
Telephone
Telephone
833.514.4187
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

BD&L Summit

BD&L Summit

Not Confirmed

envelop Contact Supplier

BD&L Summit

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20260415412276/en/Tempus-and-Predicta-Biosciences-Announce-Collaboration-to-Expand-Life-Sciences-Access-to-Ultrasensitive-Whole-Genome-Sequencing-Assay-for-Hematologic-Malignancies-and-MRD-Monitoring

BUSINESSWIRE
15 Apr 2026

https://www.businesswire.com/news/home/20260414517979/en/Tempus-Announces-31-Abstracts-for-Presentation-at-the-American-Association-for-Cancer-Research-Annual-Meeting-2026

BUSINESSWIRE
14 Apr 2026

https://www.pharmiweb.com/press-release/2026-04-13/genialis-supermodel-predicts-patient-response-to-her2-targeted-therapy-enhertu

PHARMIWEB
13 Apr 2026

https://www.businesswire.com/news/home/20260409128442/en/Tempus-Announces-Strategic-Collaboration-with-Gilead-to-Advance-Oncology-RD-Through-RWE

BUSINESSWIRE
09 Apr 2026

https://www.businesswire.com/news/home/20260317693663/en/Tempus-and-Blood-Cancer-United-Announce-Collaboration-to-Develop-One-Of-the-Largest-Pediatric-Acute-Myeloid-Leukemia-Real-World-Data-Registries

BUSSINESSWIRE
17 Mar 2026

https://www.businesswire.com/news/home/20260303796307/en/Tempus-Announces-Strategic-Collaboration-Agreement-with-Merck-to-Accelerate-AI-Driven-Precision-Medicine

BUSINESSWIRE
03 Mar 2026

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty